Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

REMOD-HEALING Targeting Extracellular Matrix Remodelling in Cutaneous Wounds to Promote Better Healing

Coordinator
Centre National De La Recherche Scientifique CNRS, France
Runs
1 November 2025 to 31 October 2029
Status
Running
EU funding
€3.6m
Total cost
—
Partners
14 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226977

What the project is doing

In the project's own words, from its summary on CORDIS.

Wound healing is a physiological process leading to the restoration of the skin barrier integrity after injury. A large number of factors (wound size and location, exogenous pathogenic agents, aging, co-morbidities, genetic diseases) can affect wound healing and prevent its normal resolution, leading to wounds that never heal (i.e. chronic wounds) or that heal in an aberrant manner (e.g. with scarring or dermonecrosis).

Wound healing disorders affect up to 6% of the adult population in the world and this number is expected to continue to grow due to population aging and increasing incidence of metabolic diseases. In addition, current therapeutic solutions lack efficiency and there is an urgent need for better diagnostic tools to improve wound management. In the REMOD-HEALING project, we propose to tackle the burden of pathological wounds by exploiting the huge reservoir of therapeutic targets and biomarkers associated with extracellular matrix (ECM) remodelling in cutaneous wounds.

Our innovative approach will be to analyse, model and target the aberrant ECM modifications induced by proteolytic enzymes in various healing disorders (chronic ulcers, epidermolysis bullosa, snake bite-induced dermonecrosis) with the hypothesis that the quality of the ECM shaped by proteases dictates the quality of tissue regeneration. We have gathered a team of 14 European and Latin American partners to provide excellent training to 12 doctoral candidates and generate breakthrough research allowing us to (i) gain a deeper understanding of proteolytic networks in normal and pathological wounds in order to identify novel potential biomarkers and protease targets (Objective 1), (ii) obtain biochemical and structural information on specific protease targets, their ECM substrates and their endogenous inhibitors to fuel the discovery of diagnostic tools and anti-protease drugs (Objective 2), (iii) develop new diagnostic and therapeutic tools to improve wound management (Objective 3).

Topics

Who is involved

OrganisationCityCountryRole
Centre National De La Recherche Scientifique CNRSParisFranceCoordinator
Paris-Lodron-Universitat SalzburgSalzburgAustriaParticipant
Universite De LiegeLiegeBelgiumParticipant
Universidad De Costa RicaSan Pedro De Montes De Oca San JoseCRParticipant
Albert-Ludwigs-Universitaet FreiburgFreiburgGermanyAssociatedpartner
Universitaet MuensterMuensterGermanyParticipant
Universitaetsklinikum FreiburgFreiburgGermanyParticipant
Danmarks Tekniske UniversitetKongens LyngbyDenmarkParticipant
Nordic Bioscience A/sHerlevDenmarkParticipant
Universite Lyon 1 Claude BernardVilleurbanne CedexFranceAssociatedpartner
Mimetas BVLeidenNetherlandsParticipant
Universiteit LeidenLeidenNetherlandsAssociatedpartner
Politechnika WroclawskaWroclawPolandParticipant
The University of ManchesterManchesterUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI